| # | Drug | Count |
|---|---|---|
| 0 | DARUNAVIR | 7 |
| 1 | RALTEGRAVIR | 7 |
| 2 | RITONAVIR | 7 |
| 3 | ABACAVIR SULFATE | 4 |
| 4 | DARUNAVIR 600 MG | 4 |
| 5 | DARUNAVIR 800 MG | 4 |
| 6 | LAMIVUDINE | 4 |
| 7 | LAMIVUDINE ORAL | 4 |
| 8 | ZIDOVUDINE | 4 |
| 9 | PREGABALIN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CERLIPONASE ALFA | 1 | 0.0019 |
| 1 | RALTEGRAVIR | 7 | 0.0013 |
| 2 | DARUNAVIR 600 MG | 4 | 0.0006 |
| 3 | DARUNAVIR | 7 | 0.0005 |
| 4 | ABACAVIR SULFATE | 4 | 0.0004 |
| 5 | ZIDOVUDINE | 4 | 0.0004 |
| 6 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 7 | RITONAVIR 100 MG | 3 | 0.0002 |
| 8 | LAMIVUDINE | 4 | 0.0002 |
| 9 | LAMIVUDINE AND ZIDOVUDINE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 7 | 0.0002 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 7 | 0.0001 |
| 2 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 3 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 4 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0001 |
| 6 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0000 |
| 9 | Muscle Relaxant [EPC] | 1 | 0.0000 |